Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer

Condition:   Prostate Cancer Interventions:   Drug: Apalutamide Oral Product;   Drug: Androgen Deprivation Therapy (ADT);   Procedure: Focal Therapy Sponsors:   University of Cincinnati;   Janssen, LP Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials